Roivant Social Ventures Archives
Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.
VUMC and Roivant Social Ventures announce collaboration to develop therapies for underserved populations
Jul. 6, 2022—Vanderbilt University Medical Center and Roivant Social Ventures (RSV) this week announced an intention to collaborate in developing therapies for traditionally underserved populations and diseases.